应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SNSE Sensei Biotherapeutics, Inc.
已收盘 11-22 16:00:00 EST
0.5211
+0.0371
+7.67%
盘后
0.5297
+0.0086
+1.65%
19:57 EST
最高
0.5416
最低
0.4720
成交量
43.14万
今开
0.4720
昨收
0.4840
日振幅
14.38%
总市值
1,311万
流通市值
862.30万
总股本
2,515万
成交额
22.05万
换手率
2.61%
流通股本
1,655万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Sensei Biotherapeutics, Inc.盘中异动 股价大涨6.03%报0.513美元
市场透视 · 04:15
Sensei Biotherapeutics, Inc.盘中异动 股价大涨6.03%报0.513美元
Sensei Biotherapeutics, Inc.2024财年第三财季实现净利润-7.25百万美元,同比减少1.83%
市场透视 · 00:02
Sensei Biotherapeutics, Inc.2024财年第三财季实现净利润-7.25百万美元,同比减少1.83%
Sensei Biotherapeutics, Inc.股价拉升10.40% 市值涨28.53万美元
市场透视 · 11-21 00:58
Sensei Biotherapeutics, Inc.股价拉升10.40% 市值涨28.53万美元
Sensei Biotherapeutics, Inc.盘中异动 股价大跌5.54%
市场透视 · 11-19
Sensei Biotherapeutics, Inc.盘中异动 股价大跌5.54%
Sensei Biotherapeutics, Inc.盘中异动 大幅上涨7.36%报0.487美元
市场透视 · 11-19
Sensei Biotherapeutics, Inc.盘中异动 大幅上涨7.36%报0.487美元
Sensei Biotherapeutics, Inc.盘中异动 股价大涨5.89%报0.489美元
市场透视 · 11-16
Sensei Biotherapeutics, Inc.盘中异动 股价大涨5.89%报0.489美元
Sensei Biotherapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要
路透中文 · 11-15
Sensei Biotherapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要
Sensei Biotherapeutics, Inc.盘中异动 早盘大幅下挫7.86%
市场透视 · 11-13
Sensei Biotherapeutics, Inc.盘中异动 早盘大幅下挫7.86%
Sensei Biotherapeutics, Inc.盘中异动 早盘股价大跌6.47%
市场透视 · 11-11
Sensei Biotherapeutics, Inc.盘中异动 早盘股价大跌6.47%
Sensei Biotherapeutics, Inc.盘中异动 临近收盘急速上涨5.08%
市场透视 · 11-08
Sensei Biotherapeutics, Inc.盘中异动 临近收盘急速上涨5.08%
Sensei Biotherapeutics, Inc.盘中异动 股价大涨6.91%报0.535美元
市场透视 · 11-07
Sensei Biotherapeutics, Inc.盘中异动 股价大涨6.91%报0.535美元
Sensei Biotherapeutics, Inc.盘中异动 早盘股价大跌5.59%报0.490美元
市场透视 · 11-05
Sensei Biotherapeutics, Inc.盘中异动 早盘股价大跌5.59%报0.490美元
Sensei Biotherapeutics, Inc.盘中异动 急速拉升5.55%报0.517美元
市场透视 · 11-04
Sensei Biotherapeutics, Inc.盘中异动 急速拉升5.55%报0.517美元
Sensei Biotherapeutics Inc 预计每股亏损 31 美分 - 财报前瞻
Reuters · 11-01
Sensei Biotherapeutics Inc 预计每股亏损 31 美分 - 财报前瞻
Sensei Biotherapeutics, Inc.盘中异动 早盘急速拉升6.26%报0.505美元
市场透视 · 11-01
Sensei Biotherapeutics, Inc.盘中异动 早盘急速拉升6.26%报0.505美元
Sensei Biotherapeutics, Inc.盘中异动 大幅跳水6.74%报0.533美元
市场透视 · 10-31
Sensei Biotherapeutics, Inc.盘中异动 大幅跳水6.74%报0.533美元
Sensei Biotherapeutics, Inc.盘中异动 股价大跌5.51%
市场透视 · 10-29
Sensei Biotherapeutics, Inc.盘中异动 股价大跌5.51%
Sensei Biotherapeutics, Inc.盘中异动 早盘股价大涨5.38%报0.590美元
市场透视 · 10-28
Sensei Biotherapeutics, Inc.盘中异动 早盘股价大涨5.38%报0.590美元
Sensei Biotherapeutics, Inc.盘中异动 股价大跌5.08%报0.560美元
市场透视 · 10-25
Sensei Biotherapeutics, Inc.盘中异动 股价大跌5.08%报0.560美元
Sensei Biotherapeutics, Inc.盘中异动 急速跳水5.68%报0.531美元
市场透视 · 10-24
Sensei Biotherapeutics, Inc.盘中异动 急速跳水5.68%报0.531美元
加载更多
公司概况
公司名称:
Sensei Biotherapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Sensei Biotherapeutics, Inc.是一家临床阶段的免疫疗法公司,于2017年12月1日在特拉华州注册成立。该公司是一家免疫肿瘤学公司,专注于癌症患者下一代疗法的发现和开发。通过TMAb(肿瘤微环境激活生物制剂)平台,公司正在开发高选择性疗法,旨在在肿瘤微环境中选择性地禁用免疫抑制信号或激活免疫刺激信号,以释放T细胞对抗肿瘤。
发行价格:
--
{"stockData":{"symbol":"SNSE","market":"US","secType":"STK","nameCN":"Sensei Biotherapeutics, Inc.","latestPrice":0.5211,"timestamp":1732309200000,"preClose":0.484,"halted":0,"volume":431423,"hourTrading":{"tag":"盘后","latestPrice":0.5297,"preClose":0.5211,"latestTime":"19:57 EST","volume":37213,"amount":19764.974049,"timestamp":1732323454861},"delay":0,"floatShares":16547667,"shares":25151129,"eps":-1.188651,"marketStatus":"已收盘","marketStatusCode":5,"change":0.0371,"latestTime":"11-22 16:00:00 EST","open":0.472,"high":0.5416,"low":0.472,"amount":220464.0989103,"amplitude":0.143802,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.188651,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1612414800000,"adjPreClose":0.484,"preHourTrading":{"tag":"盘前","latestPrice":0.491,"preClose":0.472,"latestTime":"08:10 EST","volume":2589,"amount":1291.57694133,"timestamp":1732281041579},"postHourTrading":{"tag":"盘后","latestPrice":0.5297,"preClose":0.5211,"latestTime":"19:57 EST","volume":37213,"amount":19764.974049,"timestamp":1732323454861},"volumeRatio":0.683983},"requestUrl":"/m/hq/s/SNSE","defaultTab":"news","newsList":[{"id":"2485421153","title":"Sensei Biotherapeutics, Inc.盘中异动 股价大涨6.03%报0.513美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485421153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485421153?lang=zh_cn&edition=full","pubTime":"2024-11-23 04:15","pubTimestamp":1732306504,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日04时15分,Sensei Biotherapeutics, Inc.股票出现异动,股价急速拉升6.03%。截至发稿,该股报0.513美元/股,成交量13.7224万股,换手率0.55%,振幅8.51%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.38%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123041505abd81aa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123041505abd81aa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","BK4139"],"gpt_icon":0},{"id":"2485029589","title":"Sensei Biotherapeutics, Inc.2024财年第三财季实现净利润-7.25百万美元,同比减少1.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485029589","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485029589?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:02","pubTimestamp":1732291362,"startTime":"0","endTime":"0","summary":"11月23日,Sensei Biotherapeutics, Inc.公布财报,公告显示公司2024财年第三财季净利润为-7.25百万美元,同比减少1.83%;其中营业收入为0.00美元,每股基本收益为-0.29美元。机构评级:截至2024年11月23日,当前有3家机构对Sensei Biotherapeutics, Inc.目标价做出预测,其中目标均价为4.17美元,其中最低目标价为3.50美元,最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000312abd7b928&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000312abd7b928&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE"],"gpt_icon":0},{"id":"2485476241","title":"Sensei Biotherapeutics, Inc.股价拉升10.40% 市值涨28.53万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485476241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485476241?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:58","pubTimestamp":1732121926,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日00时58分,Sensei Biotherapeutics, Inc.股票出现异动,股价快速上涨10.40%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.74%。其相关个股中,Forte Biosciences, Inc.、Exicure, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大,Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃,换手率分别为1491.97%、1213.30%、671.59%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.,振幅分别为185.64%、169.09%、136.94%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121005846abd27420&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121005846abd27420&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNSE"],"gpt_icon":0},{"id":"2484592331","title":"Sensei Biotherapeutics, Inc.盘中异动 股价大跌5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484592331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484592331?lang=zh_cn&edition=full","pubTime":"2024-11-19 22:38","pubTimestamp":1732027104,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日22时38分,Sensei Biotherapeutics, Inc.股票出现异动,股价大幅下挫5.54%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.57%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Tff Pharmaceuticals, Inc.、Hcw Biologics Inc.、Exicure, Inc.较为活跃,换手率分别为652.11%、82.53%、67.01%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tff Pharmaceuticals, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ,振幅分别为52.14%、33.02%、28.79%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223824a245f356&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119223824a245f356&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNSE"],"gpt_icon":0},{"id":"2484060591","title":"Sensei Biotherapeutics, Inc.盘中异动 大幅上涨7.36%报0.487美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484060591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484060591?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:50","pubTimestamp":1731948607,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日00时50分,Sensei Biotherapeutics, Inc.股票出现波动,股价快速上涨7.36%。截至发稿,该股报0.487美元/股,成交量22.6万股,换手率0.90%,振幅8.38%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.15%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111900500898e434fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111900500898e434fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","BK4139"],"gpt_icon":0},{"id":"2483703300","title":"Sensei Biotherapeutics, Inc.盘中异动 股价大涨5.89%报0.489美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483703300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483703300?lang=zh_cn&edition=full","pubTime":"2024-11-16 01:33","pubTimestamp":1731691994,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日01时33分,Sensei Biotherapeutics, Inc.股票出现异动,股价大幅拉升5.89%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为3.58%。其相关个股中,Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cero Therapeutics Holdings, Inc.涨幅较大,Tc Biopharm Plc、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为4361.01%、674.51%、524.62%,振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Celularity Inc C/Wts 16/07/2026 ,振幅分别为134.58%、129.73%、110.59%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116013315971a6ed1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116013315971a6ed1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","BK4139"],"gpt_icon":0},{"id":"2483332133","title":"Sensei Biotherapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483332133","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483332133?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:59","pubTimestamp":1731617960,"startTime":"0","endTime":"0","summary":"Sensei Biotherapeutics Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要Sensei Biotherapeutics Inc SNSE.OQ报告了截至9月30日的季度调整后每股亏损29美分,低于去年同期的每股收益-28美分。四位分析师对该季度的平均预期是每股亏损 31 美分。Sensei Biotherapeutics Inc 报告的季度每股收益为亏损 29 美分。该公司当季亏损 725 万美元。Sensei Biotherapeutics Inc 的股价本季度下跌了 11.1%,今年迄今为止下跌了 23.2%。华尔街对 Sensei Biotherapeutics Inc 的 12 个月目标价中位数为 4.00 本摘要由 LSEG 11 月 14 日 08:58 p.m. UTC 数据机器生成。如有任何其他问题或反馈,请联系 RefinitivNewsSupport@thomsonreuters.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4S3ML1WG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNSE"],"gpt_icon":0},{"id":"2483588207","title":"Sensei Biotherapeutics, Inc.盘中异动 早盘大幅下挫7.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483588207","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483588207?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:03","pubTimestamp":1731510202,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时03分,Sensei Biotherapeutics, Inc.股票出现异动,股价快速下跌7.86%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。其相关个股中,Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Kairos Pharma, Ltd.涨幅较大,Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃,换手率分别为363.48%、217.69%、92.49%,振幅较大的相关个股有Lexeo Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Kairos Pharma, Ltd.,振幅分别为44.21%、36.31%、28.72%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113230322971a64f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113230322971a64f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNSE"],"gpt_icon":0},{"id":"2482738792","title":"Sensei Biotherapeutics, Inc.盘中异动 早盘股价大跌6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738792","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738792?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:43","pubTimestamp":1731336199,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时43分,Sensei Biotherapeutics, Inc.股票出现波动,股价大幅下挫6.47%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.10%。其相关个股中,Cero Therapeutics Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Pyxis Oncology, Inc.涨幅较大,Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为431.62%、183.75%、90.01%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Revelation Biosciences, Inc.,振幅分别为76.29%、31.82%、22.93%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122431998e41cbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122431998e41cbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","BK4139"],"gpt_icon":0},{"id":"2481521159","title":"Sensei Biotherapeutics, Inc.盘中异动 临近收盘急速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481521159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481521159?lang=zh_cn&edition=full","pubTime":"2024-11-08 04:47","pubTimestamp":1731012476,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日04时47分,Sensei Biotherapeutics, Inc.股票出现波动,股价快速拉升5.08%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.21%。其相关个股中,Celularity Inc.、Cingulate Inc C/Wts 10/12/2026 、Bionomics Ltd Ads Each Rep 180 Ord Shs涨幅较大,Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Celularity Inc.较为活跃,换手率分别为957.17%、535.26%、204.88%,振幅较大的相关个股有Celularity Inc.、Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ,振幅分别为258.62%、204.12%、77.09%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108044756a2219af0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108044756a2219af0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","BK4139"],"gpt_icon":0},{"id":"2481937508","title":"Sensei Biotherapeutics, Inc.盘中异动 股价大涨6.91%报0.535美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481937508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481937508?lang=zh_cn&edition=full","pubTime":"2024-11-07 03:09","pubTimestamp":1730920156,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日03时09分,Sensei Biotherapeutics, Inc.股票出现波动,股价急速拉升6.91%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.75%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃,换手率分别为3347.34%、500.85%、151.26%,振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Cardio Diagnostics Holdings Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ,振幅分别为125.89%、82.72%、59.87%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107030916aba7337d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107030916aba7337d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNSE"],"gpt_icon":0},{"id":"2481650080","title":"Sensei Biotherapeutics, Inc.盘中异动 早盘股价大跌5.59%报0.490美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481650080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481650080?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:31","pubTimestamp":1730817061,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时31分,Sensei Biotherapeutics, Inc.股票出现波动,股价快速下跌5.59%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.34%。其相关个股中,Bionomics Ltd Ads Each Rep 180 Ord Shs、Zyversa Therapeutics, Inc.、Elevai Labs, Inc.涨幅较大,Zyversa Therapeutics, Inc.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Elevai Labs, Inc.较为活跃,换手率分别为2140.28%、820.90%、389.80%,振幅较大的相关个股有Bionomics Ltd Ads Each Rep 180 Ord Shs、Tevogen Bio Holdings Inc.、Zyversa Therapeutics, Inc.,振幅分别为12.86%、5.61%、5.49%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223101aba23b09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223101aba23b09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","BK4139"],"gpt_icon":0},{"id":"2480581144","title":"Sensei Biotherapeutics, Inc.盘中异动 急速拉升5.55%报0.517美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480581144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480581144?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:33","pubTimestamp":1730730782,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时33分,Sensei Biotherapeutics, Inc.股票出现异动,股价快速拉升5.55%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.22%。其相关个股中,Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Neurogene Inc.涨幅较大,Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃,换手率分别为235.28%、133.36%、43.36%,振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd.,振幅分别为29.83%、22.67%、12.78%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422330295bdca11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422330295bdca11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","BK4139"],"gpt_icon":0},{"id":"2480788730","title":"Sensei Biotherapeutics Inc 预计每股亏损 31 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480788730","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480788730?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:36","pubTimestamp":1730471770,"startTime":"0","endTime":"0","summary":" * Sensei Biotherapeutics Inc 将于11月5日公布截至2024年9月30日的财报() 预计该公司的季度收入将保持不变。* * LSEG 的分析师平均预计 Sensei Biotherapeutics Inc 每股亏损 31 美分。* 华尔街对 Sensei Biotherapeutics Inc 的 12 个月目标价中位数为 4.00 美元,高于其 0.47 美元的最新收盘价。11月1日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Sensei Biotherapeutics Inc 预计每股亏损 31 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNSE"],"gpt_icon":0},{"id":"2480889459","title":"Sensei Biotherapeutics, Inc.盘中异动 早盘急速拉升6.26%报0.505美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480889459","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480889459?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:31","pubTimestamp":1730467861,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时31分,Sensei Biotherapeutics, Inc.股票出现异动,股价急速拉升6.26%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.43%。其相关个股中,Tc Biopharm Plc C/Wts 10/02/2028 、Theriva Biologics, Inc.、Athira Pharma, Inc.涨幅较大,Theriva Biologics, Inc.、Athira Pharma, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为1177.37%、94.56%、72.82%,振幅较大的相关个股有Theriva Biologics, Inc.、Cyclerion Therapeutics, Inc.、Genelux Corporation,振幅分别为10.96%、10.73%、8.07%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101213101971a3d5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101213101971a3d5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","BK4139"],"gpt_icon":0},{"id":"2479358410","title":"Sensei Biotherapeutics, Inc.盘中异动 大幅跳水6.74%报0.533美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479358410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479358410?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:31","pubTimestamp":1730381465,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时31分,Sensei Biotherapeutics, Inc.股票出现异动,股价急速下挫6.74%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.28%。其相关个股中,Aerovate Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Mimedx Group, Inc涨幅较大,Evogene Ltd.、Aditxt, Inc.、Palisade Bio, Inc.较为活跃,换手率分别为189.40%、185.07%、144.74%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Equillium, Inc.、Aerovate Therapeutics, Inc.,振幅分别为21.98%、12.32%、8.68%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213105ab8b7f9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213105ab8b7f9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","BK4139"],"gpt_icon":0},{"id":"2479828244","title":"Sensei Biotherapeutics, Inc.盘中异动 股价大跌5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479828244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479828244?lang=zh_cn&edition=full","pubTime":"2024-10-29 23:07","pubTimestamp":1730214444,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日23时07分,Sensei Biotherapeutics, Inc.股票出现波动,股价快速跳水5.51%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.06%。其相关个股中,Glycomimetics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Lixte Biotechnology Holdings, Inc.涨幅较大,Lixte Biotechnology Holdings, Inc.、Glycomimetics, Inc.、Novabay Pharmaceuticals, Inc.较为活跃,换手率分别为940.32%、782.23%、306.00%,振幅较大的相关个股有Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ,振幅分别为160.88%、88.24%、65.41%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029230724ab7f5975&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029230724ab7f5975&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","BK4139"],"gpt_icon":0},{"id":"2478438780","title":"Sensei Biotherapeutics, Inc.盘中异动 早盘股价大涨5.38%报0.590美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478438780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478438780?lang=zh_cn&edition=full","pubTime":"2024-10-28 23:19","pubTimestamp":1730128740,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日23时19分,Sensei Biotherapeutics, Inc.股票出现波动,股价快速拉升5.38%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.38%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Monte Rosa Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Tc Biopharm Plc、Genprex, Inc.、Monte Rosa Therapeutics, Inc.较为活跃,换手率分别为662.98%、65.49%、55.25%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.,振幅分别为87.13%、84.14%、46.83%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028231900ab7bfcdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028231900ab7bfcdb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNSE"],"gpt_icon":0},{"id":"2478993917","title":"Sensei Biotherapeutics, Inc.盘中异动 股价大跌5.08%报0.560美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478993917","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478993917?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:24","pubTimestamp":1729866242,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时24分,Sensei Biotherapeutics, Inc.股票出现波动,股价快速下挫5.08%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.93%。其相关个股中,Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Elevai Labs, Inc.涨幅较大,180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm Plc较为活跃,换手率分别为717.12%、652.63%、156.75%,振幅较大的相关个股有Qualigen Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Elevai Labs, Inc.,振幅分别为91.58%、77.79%、69.41%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522240295bd59e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522240295bd59e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNSE"],"gpt_icon":0},{"id":"2477631187","title":"Sensei Biotherapeutics, Inc.盘中异动 急速跳水5.68%报0.531美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477631187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477631187?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:33","pubTimestamp":1729776836,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时33分,Sensei Biotherapeutics, Inc.股票出现异动,股价快速跳水5.68%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.42%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Cns Pharmaceuticals, Inc.、Dbv Technologies涨幅较大,Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃,换手率分别为199.63%、99.42%、33.61%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Qualigen Therapeutics, Inc.,振幅分别为45.75%、20.04%、13.79%。Sensei Biotherapeutics, Inc.公司简介:Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司,致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024213357ab70a448&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024213357ab70a448&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","CNSP","GNPX","BK4139"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.senseibio.com","stockEarnings":[{"period":"1week","weight":0.0474},{"period":"1month","weight":-0.2216},{"period":"3month","weight":-0.1862},{"period":"6month","weight":-0.3873},{"period":"1year","weight":-0.2623},{"period":"ytd","weight":-0.3006}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sensei Biotherapeutics, Inc.是一家临床阶段的免疫疗法公司,于2017年12月1日在特拉华州注册成立。该公司是一家免疫肿瘤学公司,专注于癌症患者下一代疗法的发现和开发。通过TMAb(肿瘤微环境激活生物制剂)平台,公司正在开发高选择性疗法,旨在在肿瘤微环境中选择性地禁用免疫抑制信号或激活免疫刺激信号,以释放T细胞对抗肿瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.017036},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.028319},{"month":3,"riseRate":0.25,"avgChangeRate":-0.072199},{"month":4,"riseRate":0,"avgChangeRate":-0.11328},{"month":5,"riseRate":0.25,"avgChangeRate":-0.032584},{"month":6,"riseRate":0.25,"avgChangeRate":-0.100205},{"month":7,"riseRate":0.5,"avgChangeRate":-0.045145},{"month":8,"riseRate":0.25,"avgChangeRate":0.019454},{"month":9,"riseRate":0,"avgChangeRate":-0.106369},{"month":10,"riseRate":0,"avgChangeRate":-0.138935},{"month":11,"riseRate":0.5,"avgChangeRate":-0.049235},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.048857}],"exchange":"NASDAQ","name":"Sensei Biotherapeutics, Inc.","nameEN":"Sensei Biotherapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sensei Biotherapeutics, Inc.(SNSE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sensei Biotherapeutics, Inc.(SNSE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sensei Biotherapeutics, Inc.,SNSE,Sensei Biotherapeutics, Inc.股票,Sensei Biotherapeutics, Inc.股票老虎,Sensei Biotherapeutics, Inc.股票老虎国际,Sensei Biotherapeutics, Inc.行情,Sensei Biotherapeutics, Inc.股票行情,Sensei Biotherapeutics, Inc.股价,Sensei Biotherapeutics, Inc.股市,Sensei Biotherapeutics, Inc.股票价格,Sensei Biotherapeutics, Inc.股票交易,Sensei Biotherapeutics, Inc.股票购买,Sensei Biotherapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sensei Biotherapeutics, Inc.(SNSE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sensei Biotherapeutics, Inc.(SNSE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}